Glucose Monitor Added to Lifestyle Program to Prevent Type 2 Diabetes
Tests a glucose monitor added to a prevention program in adults with prediabetes.
Plain-language title generated from the registry record
Registry title: CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
Key facts
- Where
- Buffalo, United StatesSee the site
Where in United States
- Division of Population Health, Department of MedicineBuffalo, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- State University of New York at Buffalo
- Trial code
- NCT07140848
- Record updated
- 3 November 2026
- Original description
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.Read full original descriptionShow less
A Novel Continuous Glucose Monitoring Enhanced DPP Intervention to Prevent Type 2 Diabetes in Adults With Prediabetes
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.
Inclusion: adults aged 18 years or older,; diagnosis of prediabetes, as defined by current clinical guidelines (HbA1c 5.7% to 6.4%, fasting plasma glucose 100-125 mg/dL, or 2-hour plasma glucose 140-199 mg/dL following a 75g oral glucose tolerance test),; body mass index (BMI) of at least 24 kg/m² (or 22 kg/m² for Asian Americans),; willingness to comply with all aspects of the study protocol, including attending coaching sessions and using CGM devices.
Exclusion: are currently using CGMs or have medical contraindications to CGM use, such as severe skin allergies or implantable defibrillators, or; have a diagnosis of type 1 or type 2 diabetes,; are currently enrolled in another clinical trial for prediabetes. Additionally, using validated assessments, we will exclude participants with significant dementia, alcohol or drug abuse/dependency, active psychosis, or life expectancy less than 12 months as these conditions are likely to interfere with adherence to the intervention; Individuals will be excluded from the study if they.